Cargando…

Cancer Metabolism as a New Real Target in Tumor Therapy

Detalles Bibliográficos
Autores principales:	Chiaradonna, Ferdinando, Scumaci, Domenica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227542/ https://www.ncbi.nlm.nih.gov/pubmed/34198722 http://dx.doi.org/10.3390/cells10061393

Ejemplares similares

Moving beyond the Tip of the Iceberg: DJ-1 Implications in Cancer Metabolism
por: Olivo, Erika, et al.
Publicado: (2022)

Epigenetic meets metabolism: novel vulnerabilities to fight cancer
por: Scumaci, Domenica, et al.
Publicado: (2023)

Editorial: Rising stars in cancer metabolism 2022
por: Izquierdo-Garcia, Jose Luis, et al.
Publicado: (2023)

Editorial: Metabolic reprogramming in breast cancer
por: Scatena, Cristian, et al.
Publicado: (2022)

The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring
por: Chiaradonna, Ferdinando, et al.
Publicado: (2018)

Biomarkers in Thyroid Tumor Research: New Diagnostic Tools and Potential Targets of Molecular-Based Therapy
por: Gimm, Oliver, et al.
Publicado: (2011)

Is metabolism the magic bullet for targeted cancer therapy?
por: Trajkovic-Arsic, Marija, et al.
Publicado: (2023)

Development of cancer metabolism as a therapeutic target: new pathways, patient studies, stratification and combination therapy
por: Harris, Adrian L.
Publicado: (2019)

Tumor Metabolome: Therapeutic Opportunities Targeting Cancer Metabolic Reprogramming
por: Márquez, Javier, et al.
Publicado: (2021)

Immunological targets for cancer therapy: new recognition
por: Shurin, Michael R
Publicado: (2018)

Mitochondrial Complex I Inhibitors and Forced Oxidative Phosphorylation Synergize in Inducing Cancer Cell Death
por: Palorini, Roberta, et al.
Publicado: (2013)

OPA1, a new mitochondrial target in cancer therapy
por: Herkenne, Stephanie, et al.
Publicado: (2020)

Exploration of Targeted Anti-tumor Therapy: a contribution to the development of targeted therapies
por: Normanno, Nicola, et al.
Publicado: (2020)

Resistant to Targeted Therapy - Aim for Metabolic Liabilities
por: Queiroz, André Lima, et al.
Publicado: (2018)

Lipid Metabolism as a Targetable Metabolic Vulnerability in Colorectal Cancer
por: Zaytseva, Yekaterina
Publicado: (2021)

Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth
por: Gaglio, Daniela, et al.
Publicado: (2011)

Identification of Molecular Targets and Anti-Cancer Agents in GBM: New Perspectives for Cancer Therapy
por: D’Amico, Agata Grazia, et al.
Publicado: (2023)

Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies
por: Catalano, Alessia, et al.
Publicado: (2022)

Central metabolism of functionally heterogeneous mesenchymal stromal cells
por: Barilani, Mario, et al.
Publicado: (2019)

Senescent Cells: A Potential Target for New Cancer Therapies in Older Oncologic Patients
por: Brattinga, Baukje, et al.
Publicado: (2021)

Molecular Links between Cancer and Metabolic Diseases: New Perspectives and Therapeutic Strategies for Cancer Prevention and Treatment by Targeting Nutritional Patterns and Metabolic Alterations
por: Zaiou, Mohamed, et al.
Publicado: (2023)

Data recovery and integration from public databases uncovers transformation-specific transcriptional downregulation of cAMP-PKA pathway-encoding genes
por: Balestrieri, Chiara, et al.
Publicado: (2009)

Transcriptional profiling of immortalized and K-ras-transformed mouse fibroblasts upon PKA stimulation by forskolin in low glucose availability
por: Chiaradonna, Ferdinando, et al.
Publicado: (2016)

Targeted cancer therapies
por: Yan, Li, et al.
Publicado: (2011)

Targeting in Cancer Therapies
por: Mangues, Ramon, et al.
Publicado: (2016)

Targeted therapies for cancer
por: Zhou, Zhijun, et al.
Publicado: (2022)

Acute Myeloid Leukaemia: New Targets and Therapies
por: Brown, Geoffrey, et al.
Publicado: (2017)

Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling
por: Alberghina, Lilia, et al.
Publicado: (2012)

Transient targeting of the pancreatic cancer stroma as a ‘fine-tuned’ anti-tumor and anti-metastatic therapy
por: Vennin, Claire, et al.
Publicado: (2017)

Radionuclides in Diagnostics and Therapy of Malignant Tumors: New Development
por: Tolmachev, Vladimir, et al.
Publicado: (2022)

Metabolism and Cancer: Old and New Players
por: Cerella, Claudia, et al.
Publicado: (2013)

Inflammation as a Target in Cancer Therapy
por: Leon-Cabrera, Sonia, et al.
Publicado: (2019)

Fuzzy modeling and global optimization to predict novel therapeutic targets in cancer cells
por: Nobile, Marco S, et al.
Publicado: (2020)

Cancer biomarkers for targeted therapy
por: Liu, Delong
Publicado: (2019)

Nanomedicine in Cancer Targeting and Therapy
por: Palamà, Ilaria Elena, et al.
Publicado: (2022)

Challenges in targeting the tryptophan metabolism in cancer immunotherapy
por: Schollbach, Julia, et al.
Publicado: (2021)

Targeting lipogenesis in the treatment of metabolic diseases and cancer
por: Viscarra, Jose A., et al.
Publicado: (2017)

Novel Metabolic Approaches Targeting Cancer Cells
por: Sebestyén, Anna, et al.
Publicado: (2023)

Luspatercept for transfusion-dependent β-thalassemia: time to get real
por: Musallam, Khaled M., et al.
Publicado: (2023)

Journal of Obesity & Metabolic Syndrome: A New International Journal Targeting the Pathophysiology and Treatment of Obesity and Metabolic Syndrome
por: Lim, Soo
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5sp2djkv6oprtnd5j51qsosa6c